Medicure Inc (PK) (MCUJF) Actualités

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Medicure reiterates its commitment to providing exceptional access to its branded pitavastatin (zypitamag) to people living with hiv

    MEDICURE REITERATES ITS COMMITMENT TO PROVIDING EXCEPTIONAL ACCESS TO ITS BRANDED PITAVASTATIN (ZYPITAMAG) TO PEOPLE...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER...

Annual and Transition Report (foreign Private Issuer) (20-f)

Table of Contents 0001133519MPHfalseFYDuring the year ended December 31, 2020, the Company repurchased and cancelled 552,700 for a total value of...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...